Trials / Conditions / UC (Urothelial Cancer)

UC (Urothelial Cancer)

10 registered clinical trials studyying UC (Urothelial Cancer).

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carc NCT07155044	Changhai Hospital	—
Active Not Recruiting	Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors NCT05651022	Indaptus Therapeutics, Inc	Phase 1 / Phase 2
Completed	Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carci NCT03374488	Incyte Corporation	Phase 3
Completed	Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE NCT03361865	Incyte Corporation	Phase 3
Completed	A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma NCT02872714	Incyte Corporation	Phase 2
Completed	Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients NCT02903914	Incyte Corporation	Phase 1
Completed	Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced NCT02646748	Incyte Corporation	Phase 1
Completed	A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanc NCT02318277	Incyte Corporation	Phase 1 / Phase 2
Terminated	A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously T NCT02298153	Incyte Corporation	Phase 1
Completed	Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participan NCT02178722	Incyte Corporation	Phase 1 / Phase 2